The FDA-approved drug Nelfinavir inhibits lytic cell-free transmission of human adenoviruses
F. Georgi, V. Andriasyan, R. Witte, L. Murer, S. Hemmi, L. Yu, M. Grove, N. Meili, F. Kuttler, A. Yakimovich, G. Turcatti, U. F. Greber
This paper shows that the FDA-approved drug Nelfinavir inhibits lytic cell-free transmission of certain human adenoviruses but not non-lytic transmission.
bioRxiv · May 15, 2020Microbiology